Fosmanogepix treatment for coccidioidomycosis under an expanded access program

By afschroeder • April 22, 2026

Cohen SH, Allyn P, Chow FC, Rathe J, Nanayakkara DD, Hutfles G, Vijayan T, Smith EA, Saling CF, Ilges D, Schlamm HT, Thompson GR 3rd. Fosmanogepix treatment for coccidioidomycosis under an expanded access program. Clin Infect Dis. 2026 Apr 21:ciag271. doi: 10.1093/cid/ciag271. Epub ahead of print. PMID: 42015519.

Tags: antifungal, Coccidioidomycosis, expanded access program, fosmanogepix, Infectious Diseases, Publications

Preoperative Thrombocytopenia and Risk of Periprosthetic Joint Infection After Total Knee Arthroplasty: A Propensity-Matched Cohort Study

Wiener JM, Hamad CD, Chun RF, Mehany JD, Yeaman MR, Sheppard WL, Bernthal NM. Preoperative Thrombocytopenia and Risk of Periprosthetic Joint Infection After Total Knee[...]

Maternal and congenital syphilis at a national referral center in Peru, 2023-2025

Leung W, Velásquez Vásquez C, Meza Santivañez L, Arango-Ochante P, Konda KA, Vargas SK, Cáceres C, Klausner JD, Allan-Blitz LT. Maternal and congenital syphilis at[...]

Emergence of a Bundibugyo virus variant in the 2026 outbreak in the Democratic Republic of the Congo and Uganda

Amuri-Aziza A, Luakanda-Ndelemo G, Ayitewala A, Jansen D, Adroba-Tandele P, Tebba A, Kinganda-Lusamaki E, Kanyerezi S, Kaleebu P, Ngandu C, Muruta A, Jjingo D, Nabadda[...]